Pediatrics Doctors in Fairhaven, MA Accepting Medicare

8 Pediatrics doctors found. Showing 1 - 8

Cynthia Louise Fox, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 404 Huttleston Ave, Fairhaven, MA 02719 Phone: 508-996-9333

Mrs. Lily E Khoury, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 404 Huttleston Ave, Fairhaven, MA 02719 Phone: 508-996-9333    Fax: 508-996-3443

Audrey J Webb, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 404 Huttleston Ave, Fairhaven, MA 02719 Phone: 508-966-9333

Dr. David S Chesney, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-758-3781    Fax: 508-758-4455

Dr. Anna A Ward, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 404 Huttleston Ave, Fairhaven, MA 02719 Phone: 508-996-9333    Fax: 508-996-3443

Matthew A Shurtleff, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 404 Huttleston Ave, Fairhaven, MA 02719 Phone: 508-996-9333

Dr. Saba Adel Shamoon-michaud, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 404 Huttleston Ave, Fairhaven, MA 02719 Phone: 508-996-9333    Fax: 508-996-3443

Vanda Blinn, M.D., M.P.H. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 404 Huttleston Ave, Fairhaven, MA 02719 Phone: 508-996-9333    Fax: 508-996-3443

News Archive

FDA denies FOIA regarding Gilead Sciences' Truvada correspondence, AHF sues

AIDS Healthcare Foundation (AHF) today filed a lawsuit against the Food and Drug Administration (FDA) over its denial of AHF's Freedom of Information Act (FOIA) requests regarding correspondence between the FDA and Gilead Sciences regarding its potential application to the FDA to expand the use of its AIDS drug, Truvada, for use as an HIV prevention pill for pre-exposure prophylaxis (PrEP) in uninfected individuals.

Novel approach for treating mitochondrial disorders wins Kaye prize

A novel concept for the treatment of mitochondrial disorders using directed enzyme replacement therapy (DERT) has won for a Hebrew University of Jerusalem doctoral candidate one of this year's Kaye Innovation Awards. The awards were presented at this year's 71st meeting of the Hebrew University Board of Governors.

MD Solarsciences launches new sunscreen lotion at 2011 AAD meeting

A year after its launch, the first dermatologist-driven company dedicated to primary skin cancer protection and prevention introduced its newest solar protection product - a much-anticipated tinted mineral gel sunscreen – at the 2011 AAD meeting in New Orleans.

Ideal working environment can reduce psychosocial risks and health-related problems

The way people's work is organised can harm their health by causing a range of ailments, from cardiovascular disease to problems with mental health.

Read more Medical News

› Verified 7 days ago